Camptothecin-7-yl-methanthiole: semisynthesis and biological evaluation

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Camptothecin is a potent anticancer agent, but its clinical use is limited.
• Modifications to the camptothecin scaffold are explored to improve efficacy and delivery.
• Introducing functional groups can alter drug properties and biological activity.

Purpose of the Study:

• To synthesize novel 7-modified camptothecin derivatives.
• To evaluate the antiproliferative potential of these new compounds.
• To investigate their mechanism of action and drug-target interactions.

Main Methods:

• Four-step synthesis to introduce a methylenthiol group at position 7 of camptothecin.
• Preparation of the corresponding disulfide derivative, a potential prodrug.
• Assessment of antiproliferative activity against cancer cell lines.
• Mechanism of action studies and molecular modeling.

Main Results:

• Successfully synthesized 7-methylenthiol camptothecin and its disulfide prodrug.
• The disulfide prodrug demonstrated reactivity with glutathione.
• Both derivatives exhibited significant antiproliferative activities.
• Molecular modeling confirmed maintained drug-target interactions.

Conclusions:

• 7-Modified camptothecin derivatives retain the biological activity of the parent compound.
• The methylenthiol group and disulfide prodrug strategy offer potential for enhanced cancer therapy.
• These findings support further development of camptothecin analogs.